Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Please visit www.amgen.com for more information.
Insights from fellow healthcare professionals about the role of Repatha® in reducing MI risk

Virtual Drop In:

Friday, April 16, 2021
12:00-1:00 pm

Access the virtual drop in 
Meeting #: 120 979 6553
Password: uwcvm

Contact Information:

Laura Kang
(608) 358-2273